Clinical trial

Perfenidone in Type 2 Diabetic Patients With Diabetic Neuropathy

NCT06224790

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-03-10

PhasePHASE4

Study timeline

Study start (actual)2024-03-10Date precision: day

Registry last updated2025-03-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Nephropathiesunresolved

Type 2 Diabetesunresolved

Interventions

PirfenidoneDRUG · verified · RxNorm: pirfenidone

PlaceboOTHER

Sponsors & collaborators

Sidrah Lodhilead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06224790 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.